Wave Life Sciences Ltd (WVE)

Apr 15, 2026

Wave Life Sciences plans redomicile from Singapore to U.S. - Investing.com

Apr 15, 2026

Apr 15, 2026

Wave Life Sciences Plans Redomiciling to Delaware Corporation - TipRanks

Apr 15, 2026

Apr 15, 2026

Wave Life Sciences (NASDAQ: WVE) proposes one-for-one redomiciliation to Delaware parent - Stock Titan

Apr 15, 2026

Apr 15, 2026

Wave Life Sciences plans redomicile from Singapore to U.S. By Investing.com - Investing.com Canada

Apr 15, 2026

Apr 15, 2026

Wave Life Sciences (Nasdaq: WVE) sets tax-free U.S. redomiciliation - Stock Titan

Apr 15, 2026

Apr 15, 2026

Wave Life Sciences seeks Delaware move to cut compliance costs - Stock Titan

Apr 15, 2026

Apr 15, 2026

Wave Life Sciences (WVE) price target decreased by 20.34% to 28.29 - MSN

Apr 15, 2026

Apr 14, 2026

Jefferies Maintains “Buy” Rating on Wave Life Sciences (WVE) Amid Its Improving Competitive Positioning - MSN

Apr 14, 2026

Apr 14, 2026

WVE Maintains Rating by HC Wainwright & Co. -- Price Target Lowe - GuruFocus

Apr 14, 2026

Apr 14, 2026

WVE Maintains Rating by HC Wainwright & Co. -- Price Target Lowered to $18 - GuruFocus

Apr 14, 2026

Apr 12, 2026

RBC Capital Maintains Outperform Rating on Wave Life Sciences (WVE) - Yahoo Finance

Apr 12, 2026

Apr 12, 2026

WAVE Life Sciences (NASDAQ:WVE) Downgraded to "Strong Sell" Rating by Wall Street Zen - MarketBeat

Apr 12, 2026

Apr 10, 2026

Q1 2025 WAVE Life Sciences Ltd Earnings Call Transcript - GuruFocus

Apr 10, 2026

Apr 10, 2026

WVE Stock Price, Quote & Chart | WAVE LIFE SCIENCES LTD (NASDAQ:WVE) - ChartMill

Apr 10, 2026

Apr 09, 2026

Wave Life Sciences plunges after early-stage data for obesity therapy - MSN

Apr 09, 2026

Apr 08, 2026

Wave Life Sciences Ltd. R (1U5.DU) Q1 FY2025 earnings call transcript - Yahoo Finance

Apr 08, 2026

Apr 07, 2026

RBC Capital Maintains Wave Life Sciences(WVE.US) With Buy Rating, Cuts Target Price to $15 - Moomoo

Apr 07, 2026

Apr 07, 2026

RBC Capital Adjusts Wave Life Sciences PT to $15 From $27, Maintains Outperform Rating - Moomoo

Apr 07, 2026

Apr 07, 2026

Wave Life Sciences Ltd. (WVE) PT increased to $52 at Canaccord following pipeline review - MSN

Apr 07, 2026

Apr 07, 2026

WAVE Life Sciences Ltd. (NASDAQ:WVE) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

Apr 07, 2026

Apr 06, 2026

Wave Life Sciences (WVE) Is Up 14.4% After Phase 1 Data On Long‑Acting Obesity Drug WVE‑007 - Sahm

Apr 06, 2026

Apr 06, 2026

Aug Momentum: Is Wave Life Sciences Ltd gaining market shareTrade Analysis Report & Weekly Breakout Stock Alerts - baoquankhu1.vn

Apr 06, 2026

Apr 06, 2026

A Look At Wave Life Sciences (WVE) Valuation After INLIGHT Phase 1 Obesity Data Disappoints Investors - simplywall.st

Apr 06, 2026

Apr 06, 2026

Growth Recap: Is Wave Life Sciences Ltd gaining market share2026 Drop Watch & Intraday High Probability Setup Alerts - baoquankhu1.vn

Apr 06, 2026

Apr 06, 2026

Wave Life Sciences shares plunge 30% despite encouraging obesity trial results - MSN

Apr 06, 2026

Apr 04, 2026

Wave Life Sciences Ltd. (WVE) stock price, news, quote and history - Yahoo Finance Singapore

Apr 04, 2026

Apr 04, 2026

WVE.O PE Ratio & Valuation, Is WVE.O Overvalued - Intellectia AI

Apr 04, 2026

Apr 04, 2026

WVE.O Forecast — Price Prediction for 2026. Should I Buy WVE.O? - Intellectia AI

Apr 04, 2026

Apr 04, 2026

Wave Life Sciences Ltd. (WVE) Stock Price, News, Quote & History - Yahoo! Finance Canada

Apr 04, 2026

Apr 03, 2026

Gold Royalty, Wave Life Sciences, and More Stocks See Action From Activist Investors -- Barrons.com - moomoo.com

Apr 03, 2026

Apr 02, 2026

WVE.O Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Apr 02, 2026

Apr 02, 2026

WVE.O Technical Analysis & Stock Price Forecast - Intellectia AI

Apr 02, 2026

Apr 02, 2026

Wave Life Sciences’ Weight Loss Drug Phase 1 Clinical Data Triggers Stock Volatility, Yet Differentiated Path Still Shows Promise - NAI500

Apr 02, 2026

Apr 01, 2026

Wave Life Sciences (WVE) Surges 9.5%: Is This an Indication of Further Gains? - qz.com

Apr 01, 2026

Apr 01, 2026

Wave Life Sciences Announces Positive Interim Phase 1 Data from INLIGHT: Further Improvements in Body Composition, with Clinically Meaningful Reductions in Visceral Fat and Waist Circumference, at Six Months Following Single Dose of WVE-007 - Investing News Network

Apr 01, 2026

Apr 01, 2026

Wells Fargo Maintains Wave Life Sciences(WVE.US) With Buy Rating, Cuts Target Price to $13 - Moomoo

Apr 01, 2026

Apr 01, 2026

WVE Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Apr 01, 2026

Apr 01, 2026

JPMorgan Chase & Co. Has $6.30 Million Position in WAVE Life Sciences Ltd. $WVE - MarketBeat

Apr 01, 2026

Mar 31, 2026

WVE posts interim data from phase I study on WVE-007, stock tanks - MSN

Mar 31, 2026

Mar 31, 2026

WAVE Life Sciences (NASDAQ:WVE) Shares Gap UpTime to Buy? - MarketBeat

Mar 31, 2026

Mar 31, 2026

Wave Life Sciences Stock (WVE) Opinions on INLIGHT Trial Data - Moomoo

Mar 31, 2026

Mar 31, 2026

Wave Life Sciences Obesity Data Highlights Visceral Fat Focus Over Weight Loss - Yahoo Finance

Mar 31, 2026

Mar 30, 2026

[SCHEDULE 13D/A] Wave Life Sciences Ltd. Amended Major Shareholder Report - Stock Titan

Mar 30, 2026

Mar 30, 2026

RA Capital boosts Wave Life Sciences (NASDAQ: WVE) stake with 8.8M-share open-market buy - Stock Titan

Mar 30, 2026